
The episode discusses the limitations of a blood test for cancer screening, including issues with false positives and negatives.
A blood test used for population based cancer screening fell short of allowing cancers to be detected earlier, was cost prohibitive and delayed diagnoses for others, a new study shows. Johns Hopkins Kimmel Cancer Center director William Nelson says both … What do false positives and negatives have to do with screening tests for cancer? Elizabeth Tracey reports Read More »
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.